Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Update on bb2121 for relapsed myeloma

Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
Update on bb2121 for relapsed myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
15 Jun 2018

Repurposing selective PDE5 inhibitors as anti-cancer agents

Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium
Repurposing selective PDE5 inhibitors as anti-cancer agents ( Dr Pan Pantziarka - Anticancer Fund, Brussels, Belgium )
5 Jun 2018

First results of DREAM trial of frontline durvalumab for mesothelioma

Prof Anna Nowak - The University of Western Australia, Perth, Australia
First results of DREAM trial of frontline durvalumab for mesothelioma ( Prof Anna Nowak - The University of Western Australia, Perth, Australia )
5 Jun 2018

Results from the phase I ICONIC trial

Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
Results from the phase I ICONIC trial ( Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA )
4 Jun 2018

Chemotherapy plus durvalumab in triple negative breast cancer

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Chemotherapy plus durvalumab in triple negative breast cancer ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
4 Jun 2018

Phase II results of olaparib and abiraterone for mCRPC

Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK
Phase II results of olaparib and abiraterone for mCRPC ( Prof Noel Clarke - Salford Royal NHS Foundation Trust, Salford, UK )
4 Jun 2018

Global treatment pattern variations in HCC

Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico
Global treatment pattern variations in HCC ( Dr Nahum Mendez-Sanchez - Medica Sur Clinic and Foundation, Mexico City, Mexico )
4 Jun 2018

Design and interim safety analysis of GeparX trial

Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany
Design and interim safety analysis of GeparX trial ( Prof Sibylle Loibl - German Breast Cancer Group, Frankfurt, Germany )
4 Jun 2018

International cancer control plans

Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana
International cancer control plans ( Dr Verna Vanderpuye - Korle Bu Teaching Hospital, Accra, Ghana )
4 Jun 2018

Economic impact of NGS in non small cell lung cancer

Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA
Economic impact of NGS in non small cell lung cancer ( Dr Nathan Pennell - Cleveland Clinic Cancer Center, Cleveland, USA )
4 Jun 2018

Subcutaneous daratumumab shows benefit in patients with relapsed or refractory multiple myeloma

Dr Ajai Chari - Mount Sinai Hospital, New York, USA
Subcutaneous daratumumab shows benefit in patients with relapsed or refractory multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )
4 Jun 2018

Avelumab in combinations for lung cancer and update from ALEX study

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Avelumab in combinations for lung cancer and update from ALEX study ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
4 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation